On the recordApril 18, 2023
I am concerned that the lack of face-to-face meetings may be negatively affecting the FDA's ability to keep pace and retain its scientific and regulatory stature as the gold standard.
Source
congress.govI am concerned that the lack of face-to-face meetings may be negatively affecting the FDA's ability to keep pace and retain its scientific and regulatory stature as the gold standard.
Collins expresses concern over the impact of virtual meetings on FDA's effectiveness.
Share
More from Susan Collins
It’s a critical program and the foundation of retirement income for most Mainers, and I’ve voted repeatedly to preserve it.
I believe that we should create a commission of independent financial experts to give us advice on what should be done.